Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients

Vaccine. 2021 Apr 28;39(18):2489-2490. doi: 10.1016/j.vaccine.2021.03.086. Epub 2021 Mar 30.
No abstract available

Keywords: BNT162b2; COVID-19; SARS-CoV-2; mRNA-1273.

MeSH terms

  • Antibodies, Viral*
  • BNT162 Vaccine
  • COVID-19 Vaccines
  • Immunoglobulin G
  • Spike Glycoprotein, Coronavirus
  • Vaccines*

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • Immunoglobulin G
  • Spike Glycoprotein, Coronavirus
  • Vaccines
  • BNT162 Vaccine